4579 — RaQualia Pharma Share News
0.000.00%
Last trade - 00:00Brief: RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan
Brief: RaQualia Pharma gets sodium channel blocker patent allowance in China
Table: RaQualia Pharma -6-MTH parent results
Brief: RaQualia Pharma says sodium channel blocker patent allowance in China
Brief: RaQualia Pharma receives patent recognition for sodium channel blocker from EU
Brief: RaQualia Pharma gets FDA approval
Table: RaQualia Pharma -2016 parent forecast
Table: RaQualia Pharma -2015 parent results
Table: RaQualia Pharma -2015 parent forecast
Table: RaQualia Pharma -2015 parent forecast
Table: RaQualia Pharma -2015 parent forecast
Table: RaQualia Pharma -2015 parent forecast
Table: RaQualia Pharma -9-MTH parent results